| Literature DB >> 9532157 |
R J Corry1, M F Egidi, R Shapiro, A Sugitani, H A Gritsch, M L Jordan, S F Dodson, C A Vivas, V P Scantlebury, A S Rao, J J Fung, T E Starzl.
Abstract
In this series, antilymphoid induction therapy did not appear to be necessary to prevent early graft loss from rejection. In addition, we have followed cytomegalovirus (CMV) antigenemia (pp65) for CMV infection. Although some patients developed a positive antigenemia in the seropositive to negative donor-recipient combinations, only one patient had a prolonged febrile course for 1 week.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9532157 PMCID： PMC2977929 DOI： 10.1016/s0041-1345(97)01385-7
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066